90
Participants
Start Date
August 1, 2025
Primary Completion Date
May 31, 2028
Study Completion Date
June 30, 2028
Artesunate
Low Dose Artesunate: 2.4 mg/kg IV artesunate once daily for 14 days + GCV or VGCV and SOC per local institutional practices High Dose Artesunate: 4.8 mg/kg IV artesunate once daily for 14 days + GCV or VGCV and SOC per local institutional practices
Ganciclovir (GCV)
Standard Treatment Ganciclovir: GCV or VGCV and SOC per local institutional practices
RECRUITING
Westmead Hospital, Westmead
RECRUITING
Princess Alexandra Hospital, Woolloongabba
Lead Sponsor
Amivas Inc.
INDUSTRY